A S Koster
Overview
Explore the profile of A S Koster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mulder L, Wouters A, Somra S, Koster A, Ravesloot J, Croiset G, et al.
BMC Med Educ
. 2024 Oct;
24(1):1157.
PMID: 39415185
Higher education institutions increasingly aim to implement equity in admissions. However, there is no one-size-fits-all solution to determine which equitable admissions procedures are suitable in a specific context, nor which...
2.
Fikrat-Wevers S, Stegers-Jager K, Afonso P, Koster A, Van Gestel R, Groenier M, et al.
Adv Health Sci Educ Theory Pract
. 2023 Jan;
28(4):1027-1052.
PMID: 36653557
Student diversity in health professions education (HPE) can be affected by selection procedures. Little is known about how different selection tools impact student diversity across programs using different combinations of...
3.
Westein M, Koster A, Daelmans H, Bouvy M, Kusurkar R
Adv Health Sci Educ Theory Pract
. 2022 Sep;
28(1):205-222.
PMID: 36094680
The combination of measuring performance and giving feedback creates tension between formative and summative purposes of progress evaluations and can be challenging for supervisors. There are conflicting perspectives and evidence...
4.
Harmsen S, Koster A, Beijnen J, Schellens J, Meijerman I
Drug Metab Dispos
. 2008 Mar;
36(6):1166-71.
PMID: 18347084
Since CYP3A4 is responsible for the biotransformation of over 50% of all clinically used drugs, induction results in an increased clearance of many concomitantly administered drugs, thereby decreasing treatment efficacy...
5.
Struik M, Steenbergen H, Koster A, BRETSCHNEIDER F, Peters R
Comp Biochem Physiol A Mol Integr Physiol
. 2002 Mar;
130(3):607-13.
PMID: 11913470
The transduction pathway of ampullary electroreceptor organs involves ionic currents. It has been shown that calcium, as well as sodium and potassium play important parts in this process. In this...
6.
Muijsers R, Van Ark I, Folkerts G, Koster A, van Oosterhout A, Postma D, et al.
Br J Pharmacol
. 2001 Sep;
134(2):434-40.
PMID: 11564663
1. The contribution of reactive nitrogen species to the development of airway hyperresponsiveness in a mouse model of allergic inflammation was investigated by the use of selective inhibitors of nitric...
7.
Houtman R, Koster A, Nijkamp F
Clin Exp Allergy
. 2001 Jun;
31(6):817-22.
PMID: 11422144
No abstract available.
8.
Houtman R, Ten Broeke R, Blalock J, Villain M, Koster A, Nijkamp F
J Immunol
. 2001 Jan;
166(2):861-7.
PMID: 11145661
Release of allergic mediators from mast cells is enhanced by very late Ag (VLA)-5-mediated interaction of these cells with fibronectin. In this report, we show that VLA-5-mediated adhesion of bone...
9.
Muijsers R, van den Worm E, Folkerts G, Beukelman C, Koster A, Postma D, et al.
Br J Pharmacol
. 2000 Jun;
130(4):932-6.
PMID: 10864902
Peroxynitrite (ONOO(-)) the highly reactive coupling product of nitric oxide and superoxide, has been implicated in the pathogenesis of an increasing number of (inflammatory) diseases. At present, however, selective peroxynitrite...
10.
Kraneveld A, Muis T, Koster A, Nijkamp F
Am J Physiol
. 1998 Jun;
274(5):G832-9.
PMID: 9612263
Previously, it was shown that depletion and stabilization of the mucosal mast cell around the time of challenge were very effective in reducing delayed-type hypersensitivity (DTH) reactions in the small...